Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: A systematic review and meta-analyses

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 7, 2014, Pages 1159-1170

  Cheng, Xiang ^a   Sun, Ping ^a   Hu, Qing Gang ^a   Song, Zi Fang ^a   Xiong, Jun ^a   Zheng, Qi Chang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Transarterial chemoembolization; Transarterial embolization

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COCHRANE LIBRARY; DISEASE FREE SURVIVAL; DRUG FEVER; DRUG SAFETY; EMBASE; FEVER; HUMAN; LANGUAGE; LIVER CELL CARCINOMA; MEDLINE; META ANALYSIS; NAUSEA AND VOMITING; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PUBLICATION; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SCISEARCH; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; EMBOLIZATION, THERAPEUTIC; ENDOVASCULAR PROCEDURES; HUMANS; LIVER NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 84904135912     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1677-4     Document Type: Review

References (46)

1. Alazawi W, Cunningham M, Dearden J, Foster GR (2010) Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther 32:344-355
2. Bonfil RD, Bustuoabad OD, Ruggiero RA, Meiss RP, Pasqualini CD (1988) Tumor necrosis can facilitate the appearance of metastases. Clin Exp Metastasis 6:121-129 (Pubitemid 18065799)
3. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
4. Bruix J, Llovet JM, Castells A, Montañá X, Brú C et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578-1583 (Pubitemid 28264682)
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430 (Pubitemid 32844200)
6. Chua TC, Liauw W, Saxena A, Chu F, Glenn D et al (2010) Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Live int 30:166-174
7. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
8. Emerson JD, Burdick E, Hoaglin DC, Mosteller F, Chalmers TC (1990) An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials 11:339-352
9. Fattovich G, Stro Volini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(suppl):35-50
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
11. Higgins J, Green S (2010) Cochrane handbook for systematic reviews of interventions. Wiley, Hoboken
12. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K et al (1993) Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71:19-25 (Pubitemid 23019276)
13. Izumi R, Shimizu K, Iyobe T, Li T, Yagi M et al (1994) Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 20:295-301 (Pubitemid 24233352)
14. Jian HZ, Le QL (2010) Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: a metaanalysis. Hepatol Res 40:943-953
15. Kaibori M, Tanigawa N, Kariya S, Ikeda H, Nakahashi Y et al (2012) A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma. Dig Dis Sci 57:1404-1412
16. Kanmematsu T (1996) Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma? Hepatogastroenterology 43:1404
17. Kjaergard L, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135:982-989 (Pubitemid 33131619)
18. Lau WY, Leung TW, Yu SC, Ho SK (2003) Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171-179 (Pubitemid 38173243)
19. Lau WY, Lai EC, Leung TW, Yu SC (2008) Adjuvant intra-arterial iodine 131 labeled lipiodol for curative resection hepatocellular: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 247:43-48
20. Li J, Zhang Y, Zhang W, Yuan Y, Li G (1995) Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin 121:364-366
21. Li Q, Wang J, Sun Y, Cui YL, Juzi JT et al (2006) Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases. Dig Surg 4:235-240 (Pubitemid 44651423)
22. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442 (Pubitemid 36152543)
23. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D et al (2003) Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17:1247-1261 (Pubitemid 36693726)
24. Moher D, Pham B, Jones A, Cook DJ, Jadad AR et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet 352:609-613 (Pubitemid 28380142)
25. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264-269
26. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON et al (2001) Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 88:515-522 (Pubitemid 32291231)
27. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834 (Pubitemid 28562978)
28. Peng BG, He Q, Li JP, Zhou F (2009) Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 198:313-318
29. Poon RT, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10-24 (Pubitemid 30456545)
30. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
31. Strasberg SM, Belghiti J, Clavn P-A, Garden JO, Lau WY et al (2000) The Brisbane 2000 terminology of liver anatomy and resection. Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2:333-339
32. Tang Z, Zhou X, Lin Z, Yang B, Ma Z et al (1999) Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Chin Med J (Engl) 112:887-891
33. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer I 92:205-216
34. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:1-16
35. Wood L, Egger M, Gluud L, Schulz KF, Jüni P et al (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clin Res Ed) 336:601-605 (Pubitemid 351439518)
36. Wu CC, Ho YZ, Ho WL, Wu TC, Wu TJ et al (1995) Preoperative transcatheter arterial chemoembolization for curative resection large hepatocellular carcinoma: a reappraisal. Br J Surg 82:122-126
37. Xiao EH, Li JQ, Huang JF (2004) Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization. World J Gastroenterol 10:190-194
38. Xiao EH, Guo D, Bian DJ (2009) Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells. World J Gastroenterol 15:4582-4586
39. Xu F, Huang YQ, Li YS, Wu L, Yang JM (2012) Is postoperative adjuvant transchatheter arterial chemoembolization necessary for small hepatocellular carcinoma patients: a randomized controlled trial. Acad J Second Mil Med Univ 33:274-279
40. Yamasaki S, Hasegawa H, Kinoshita H, Masato F, Shingi I et al (1996) A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 2:206-211 (Pubitemid 26099497)
41. Yu XZ, Zhou WZ, Hu WH, Yu C, Xu B et al (2009) The efficacy of transarterial chemoembolization for hepatocellular carcinoma after curative resection. J Pract Med 25:1819-1821
42. Zhong C, Guo RP, Li JQ, Shi M, Wei W et al (2009) A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin 10:1437-1445
43. Zhong JH, Li H, Li LQ, You XM, Zhang Y et al (2012) Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials. EJSO 38:286-295
44. Zhou XD (2002) Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int 1:35-41
45. Zhou WP, Lai ECH, Li AJ, Fu SY, Zhou JP et al (2009) A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for curative resection large hepatocellular carcinoma. Ann Surg 249:195-202
46. Zhou YM, Zhang XF, Wu LP, Ye F, Su X et al (2013) Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma. BMC Gastroenterol 13:51